ABSTRACT
I
n a survey on the prevalence of chronic conditions, it was estimated that 15.5% of the total population of the United States had chronic rhinosinusitis (CRS), defined as "sinus trouble" that lasts for Ͼ3 months in the year before the interview. 1 A questionnaire on the European Position Paper on Rhinosinusitis and Nasal Polyps criteria was recently sent to a random sample of 15-to 75-year-old patients at 19 centers in Europe, and the overall prevalence of CRS according to the European Position Paper on Rhinosinusitis and Nasal Polyps criteria was 10.9% (range, 6.9-27.1%). 1 Although CRS is the sixth most common chronic condition in the elderly, 2 very few studies have been conducted on the prognosis after surgical treatment for CRS in the geriatric population. [2] [3] [4] [5] In the available international literature, there is a dearth of investigation on the characteristics of CRS with nasal polyps (CRSwNP), and its prognosis after functional endoscopic sinus surgery (FESS) , that focused exclusively on elderly patients (Ն65 years old).
The main end point of the present investigation was to review our experience gained between 2009 and 2015 with the treatment of CRSwNP in elderly patients when using FESS. Secondary aims were to analyze the variables that relate to the prognosis for CRSwNP in elderly patients and to compare the demographic, clinical, laboratory, pathologic, and prognostic characteristics of CRSwNP in elderly versus young adult patients (20 years Յ age Յ40 years, in accordance with Feldman 6 ).
METHODS

Patients
The present investigation was approved in 2015 by our Section's in-house committee. The study was carried out in accordance with the principles of the Helsinki Declaration.
Adult patients with evidence of polyps protruding below the middle turbinate (grade 2, or with massive polyps invasion (grade 3) (according to Mackay and Lund, 1997 7 ) were first treated medically for 3 months with the following: local mometasone furoate 200 g daily (100 g/nostril) (the dosage recommended by Stjärne et al. 8 ), or with fluticasone furoate 110 g daily (55 g/nostril), and in both cases oral therapy with methylprednisolone (32 mg daily on days 1-5, then 16 mg daily on days 6-10, and 8 mg daily on days 11-20) (as suggested by Van Zele et al. 9 ). If this medical therapy failed, patients underwent FESS (ethmoidectomy, middle antrostomy, sphenoidotomy, and/or frontal sinusotomy, depending on the location of the polyps), with septoplasty and turbinoplasty if necessary, with the patient under general anesthesia. Patients with polyps seen only under the middle turbinate (grade 1 7 ) were not treated surgically.
Between January 2009 and June 2015, FESS was performed for CRSwNP by the same team in 269 patients (168 men, 101 women; mean age Ϯ standard deviation [SD] ϭ 49.3 Ϯ 15.1 years). Before surgery, all the patients signed a detailed informed consent. For the purposes of the present study, our exclusion criteria were a postoperative follow-up of Ͻ3 months and a diagnosis of eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome), cystic fibrosis, diabetes, glaucoma, or severe osteoporosis. Patients with neurologic diseases and/or psychiatric disorders, and pregnant or nursing women were excluded from the study. This approach left 43 consecutive elderly patients (Ն65 years old) and 71 consecutive young adult patients (20-40 years old) with CRSwNP who were enrolled in the present study. The mean (SD) age of the elderly group (27 men and 16 women) was 72.4 Ϯ 4.9 years, whereas the young adult group (44 men and 27 women) were a mean (SD) of 31.4 Ϯ 5.8 years old.
For all the patients, the preoperative diagnostic workup included nasal endoscopy (with rigid 0°and 30°[Ø 4 mm] optical instruments),
nasal cytology, serum eosinophil and basophil counts, total and specific serum immunoglobulin E assays for common airborne allergens, serum eosinophil cationic protein levels, and paranasal high-resolution computerized tomography. Patients with asthma underwent spirometry with methacholine challenge. After surgery, the patients performed nasal irrigations with isotonic saline solution twice a day (by using 20 mL per irrigation) and received local nasal therapy with mometasone furoate 200 g daily (100 g/ nostril) by using the dosage recommended by Stjä rne et al. 8 or fluticasone furoate 110 g daily (55 g/nostril). All laboratory tests were performed before surgery, at least 3 months after withdrawing oral steroids, and at least 1 month after stopping nasal steroid treatment. During periods of pollination, patients with a known allergy to pollen were treated with antihistamines. Patients with asthma received appropriate therapy.
Clinical History and Features
We identified patients with a history of aspirin intolerance. For the diagnosis of eosinophilic granulomatosis with polyangiitis, we considered the American Rheumatism Association criteria, revised in 2012 by the International Chapel Hill Consensus Conference on the Nomenclature of Vasculitides. 10 
Laboratory Features: Serum Eosinophil and Basophil Counts
All the patients had a blood sample taken on the day of FESS to obtain their eosinophil and basophil counts. Absolute values and percentages were recorded, and the means (SDs) are reported. We also measured serum total immunoglobulin E and specific immunoglobulin E for Dermatophagoides pteronyssinus and Dermatophagoides farinae, birch pollen, pellitory, grass mix, cat and dog dander, Alternaria alternata, Aspergillus fumigatus, and common ragweed. All the assays were performed at the same laboratory (the EIA Unit, Laboratory Medicine Service, Padova General Hospital).
Histopathologic Features: Eosinophil Component in Polyps
Three high-power fields (ϫ400 magnification) from each surgical specimen were examined to quantify the eosinophil component, and two patterns of polyposis were recognized, one rich in eosinophils (Ն10 eosinophils per field) and the other poor in eosinophils (Ͻ10 eosinophils per field).
Follow-up
Patients underwent postoperative nasal endoscopy while under topical anesthesia (lidocaine 20 mg/mL plus xylometazoline 1 mg/mL; 1:1 vol/vol). Endoscopic follow-ups were performed by using rigid 0°and 30°(Ø 4 mm) instruments and scheduled 3, 6, and 12 months, and then yearly after surgery. We considered patients with recurrences as those with endoscopic evidence of at least grade I polyposis.
Statistical Analysis
The Fisher's exact test and the Mann-Whitney U test, as appropriate, were used to investigate the association between clinical, laboratory, and pathologic variables and prognosis in a univariate statistical setting. A p value of Ͻ0.05 was considered significant, whereas p values 0.1-0.05 were assumed to indicate a statistical trend. The STAT statistical package 8.1 (Stata Corp, College Station, TX) was used for all analyses.
RESULTS
FESS for CRSwNP and Disease Recurrence: The Elderly Group
Five of the 43 elderly patients (11.6%) developed recurrent CRSwNP after a mean (SD) of 21.6 Ϯ 9.0 months. The clinical, laboratory, and pathologic features of the elderly patients who had CRSwNP with and without recurrences after FESS are summarized in Table 1 . The Fisher's exact test disclosed significant associations between CRSwNP recurrence and allergy (p ϭ 0.037), CRSwNP recurrence and asthma (p ϭ 0.017), and CRSwNP recurrence and acetyl salicylic acid (ASA) intolerance (p ϭ 0.032). The laboratory findings revealed no associations between CRSwNP recurrence and serum eosinophil count (Mann-Whitney U test, p ϭ 0.18), percentage of serum eosinophils (Mann-Whitney U test p ϭ 0.12), serum basophil count (Mann-Whitney U test, p ϭ 0.54), or percentage of serum basophils (Mann-Whitney U test, p ϭ 0.31). From a pathologic viewpoint, there was no association between recurrence rate and eosinophilic-type/noneosinophilic-type CRSwNP in the group of elderly patients (p ϭ 0.34, Fisher's exact test).
FESS for CRSwNP and Disease Recurrence: Young Adult Group
Twenty of the 71 patients in this group (28.2%) developed recurrent CRSwNP after a mean (SD) of 24.6 Ϯ 8.9 months. The clinical, labo- 
CRSwNP Features and Prognosis: Elderly versus Young Adult Patients
From a clinical standpoint, the proportion of patients with allergy among the young adults was significantly higher than in the elderly group (31/71 versus 8/43; p ϭ 0.008, Fisher's exact test); however, there were no significant differences in the distribution of asthma (16/71 versus 12/43; p ϭ 0.65, Fisher's exact test) or ASA intolerance (7/71 versus 3/43; p ϭ 0.74, Fisher's exact test) among the patients in the two groups.
Statistical analyses (Mann-Whitney U test) on the preoperative laboratory data ruled out any significant differences between the elderly and young adults groups in terms of the mean (SD) serum eosinophil count (0. There was no statistically significant difference in the distribution of cases of CRSwNP with eosinophilic/noneosinophilic histologic types in the two age groups (p ϭ 1, Fisher's exact test,). As for the prognostic implications, the CRSwNP recurrence rate was lower in the elderly than in the young adults (5/43 versus 20/71, respectively; p ϭ 0.05 [trend toward significance], Fisher's exact test).
DISCUSSION
Only a few studies investigated age as a factor that influences the outcome after FESS for CRSwNP. 11, 12 The main strengths of the present study were in the homogeneous series of patients considered, given that (i) surgical treatments were all performed consecutively by the same group, with the same indications; (ii) the histologic diagnosis was established by the same pathologist (A.F.); (iii) the laboratory tests were performed at the same laboratory; and (iv) postoperative medical treatments were reasonably standardized. The main weaknesses of our study, however, concerned the retrospective setting and the limited number of patients with recurrent CRSwNP.
When we compared two consecutive series of elderly and young adult patients with CRSwNP, our statistical analysis found a lower recurrence rate in the elderly than in the young adults (p ϭ 0.05). In 2007, Lee and Lee 11 analyzed the outcome of FESS for CRSwNP in three groups of 20 patients classified by age and concluded that the objective endoscopic surgical outcome was worst in the pediatric group, whereas the geriatric group had the best results. Shin et al. 13 postulated that the geriatric population's better outcome could be due to a lesser proliferation and angiogenesis within the polyps. They described a stronger immunohistochemical expression and positive reactivity of proliferating cell nuclear antigen and Ki67 in the young adult patients' (20-30 years old) polyps than in those of the elderly patients (Ն65 years old), whereas vascular endothelial growth factor expression did not differ between the two groups. They thus concluded that cell proliferation could be the reason for the different surgical outcomes between the two age groups.
Another study 14 showed an increase in memory regulatory T (T reg ) cells in elderly individuals, together with an overall reduction in "effector" memory T CD4
ϩ subsets: both T-helper (Th) 1 and Th2 cell levels were largely maintained in older individuals' circulation, whereas their Th17 cell levels dropped. The overall T reg to effector T (T eff ) ratio was higher in the elderly's memory CD4 ϩ T-cell compartment than in that of younger individuals. This relative increase in memory T reg cells in the elderly was found to be associated with a poor response to influenza vaccination. So healthy aging would substantially tilt the T reg :Th17 balance in favor of the T reg cells. This might be essential to preventing aging-related immune-mediated diseases (e.g., rheumatoid arthritis) by keeping an anti-inflammatory microenvironment, but it may also hamper effective immunity against tumor cells and microbes, e.g., influenza virus. 14 When we looked at the clinical features reportedly often associated with recurrent CRSwNP, some (asthma and ASA intolerance 15 ) were found to be significantly related with the recurrence rate in both of our age groups, whereas our statistical analysis disclosed a significant association between CRSwNP recurrence and allergy only in the elderly group of patients, although the proportion of patients with allergy in our young adult group was significantly higher than among the elderly. There is emerging evidence that asthma in older adults is phenotypically distinct from the condition seen in younger patients. The impact of the aging process on the immunologic pathways that underpin asthma in the aging lung is still not clear, and epigenetic, environmental, and/or microbiologic triggers might be involved. The role of allergic asthma diminishes with age, however, and its different phenotypic picture in the elderly reveals normal eosinophils and elevated sputum neutrophils.
Neutrophilic asthma is associated with innate immune pathways, which possibly involve natural killer T/Th17 lymphocytes, unlike Th2-mediated allergic asthma. This means that what looks like the same disease might involve different pathogenic processes and specific immune effector cells in an age-related fashion. 16 There are widespread reports of eosinophilic-type CRSwNP being a histologic variant of CRSwNP that carries a high risk of recurrence after FESS. 17, 18 Some reasons why eosinophilic infiltration should significantly affect CRSwNP outcome have recently been advanced in the literature. For instance, eosinophilic and noneosinophilic polyps are suggested to be two distinct entities in genetic and protein expression patterns. 19 In the group of young adults with CRSwNP in the present study, the eosinophilic-type histology confirmed a strong association with a high recurrence rate, and our statistical analysis showed significant direct associations between CRSwNP recurrence and serum eosinophil count and between CRSwNP recurrence and percentage of serum eosinophils. Although the distribution of the eosinophilic and noneosinophilic types did not differ significantly between the two age groups in our study, histologic evidence of an important eosinophilic infiltration was not related with a higher recurrence rate in the elderly group of patients.
Moreover, preoperative laboratory findings in the elderly group revealed no associations between CRSwNP recurrence and serum eosinophil count or percentage of serum eosinophils. Mathur et al. 20 examined eosinophils isolated from peripheral blood for in vitro functional activity in younger (20-to 40-year-old) and older (55-to 80-year-old) patients with asthma, finding that (i) eosinophil degranulation in response to interleukin-5 stimulation was significantly less evident in the older group, and (ii) eosinophil production of superoxide anions in response to phorbol myristate acetate was lower in the older group (although the difference did not reach statistical significance). The investigators concluded that diseases, e.g., asthma, might exhibit important clinical differences in the elderly due to age-related changes in inflammatory cell function. Another study that explored airway inflammation showed that sensitized old mice had a greater airway eosinophilia in response to ovalbumin challenge than did young mice, but their airway hyperresponsiveness was less acute 21 ; in other words, despite an increased airway eosinophilia, the airway hyperresponsiveness attributable to eosinophil effector function was lower in old mice than in younger mice. In another study, sensitization and airway challenge with ovalbumin in old rats prompted a lack of eosinophil accumulation in the airway that was attributed to an age-related decrease in T-cellderived chemotactic signaling for the recruitment of eosinophils. 22 Aging is a natural process that involves physiologic changes in organ systems that reduce their functional capacity. As with other organs, the immune system undergoes remodeling over the years and changes or impairments in specific functions may occur with age. Immune-mediated diseases, including CRSwNP, may also be influenced by aging. Both innate and adaptive immunity can undergo senescence, which results in a weaker immediate response to bacterial and viral pathogens and that affects the ability to integrate and influences the adaptive immune response. In terms of CRSwNP pathogenesis, aging may involve eosinophils and T reg -T eff cell balance, as discussed above, but it may also affect antigen presentation. The extent of immunosenescence in human dendritic cells (DC), for example, remains an area of ongoing study. In general, the antigenpresenting functions of human DCs seem to be largely preserved in aging.
Age-associated defects in the antigen-presenting function have also been described; however, for example, an age-associated defect in lipopolysaccharide-induced interleukin 12 production in myeloid DCs. Moreover, little is known about the impact of aging on basophils, any increase of which can be important in the onset and recurrence of CRSwNP. 12 Basophil degranulation was reportedly impaired in one cohort of elderly individuals, whereas a later study found basophil reactivity higher in old people. Given the increasing evidence that basophils, T cells, and DCs can promote Th2 induction in a coordinated way, and their possible implication in the natural history of CRSwNP, studies are needed on aging humans to examine these newly discovered functions. 23 Aging is also characterized by an increasing likelihood of comorbid conditions and the use of several types of medication, such as bisphosphonates, nonsteroidal anti-inflammatory drugs, antihypertensives, antidepressants, and vitamins. This raises the question of whether any of these concomitant conditions and/or medications may influence the development or recurrence of CRSwNP, a question that can only be addressed by studies on large cohorts.
CONCLUSION
The present preliminary study found a lower CRSwNP recurrence rate after FESS in elderly patients than in young adult patients. Although eosinophilic-type CRSwNP is generally considered a variant of CRSwNP at high risk of recurrence, and our research group recently hypothesized that a stricter postoperative follow-up and adjuvant postoperative medical treatment might be warranted for patients with eosinophilic-type CRSwNP, such an approach could not be justified in the case of elderly patients.
